IV, Fenoldopam Two

IV fenoldopam is a short‑acting selective D1‑receptor agonist used for rapid blood pressure reduction.

gmgmcg
mlL
kglbs
mg/kg/minmg/kg/hrmcg/kg/minmcg/kg/hr

Indications d'utilisation

Used for hypertensive emergencies, especially with acute kidney injury, where it provides controlled BP reduction while increasing renal blood flow (AHA/ACC 2025) 1 [Level I evidence]. Clinically lowers BP dose‑dependently and is an alternative to nitroprusside (JAMA RCT) 2 [Level II evidence]. Not effective for preventing/treating established AKI in large RCTs (JAMA 2014) 3 [Level I evidence].

Informations et précautions

Start at 0.1–0.3 mcg/kg/min IV, titrating every 15 minutes; expect rapid BP fall (5–15 min) but monitor closely for hypotension, which increases significantly in RCTs (26% vs 15%, P=0.001) 1 [Level I evidence]. Avoid in glaucoma, intracranial hypertension, or sulfite allergy per AHA/ACC guidance 2 [Level I evidence]. Renal protection is inconsistent, with large RCTs showing no reduction in AKI or RRT 3 [Level I evidence].